CAS RN: 1620959-59-2

Benzoic acid, 4,4′,4”,4”’-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2,3,13,14-tetrayl)tetrakis-

Product Availability

Choose a grade to view its available package options.

5 package records5 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260324 100mg In stock Shanghai, Tianjin Inquiry
Batchno.20250114 1g In stock Shanghai, Shenzhen Inquiry
Batchno.20250111 250mg In stock Shanghai Inquiry
Batchno.20250101 50mg / 250mg / 1g Confirm by inquiry Shanghai 5-7 business days Inquiry
Batchno.20260212 5g In stock Shanghai Inquiry
  • Product code: starshine_CAS1620959-59-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1620959-59-2 / 4-[12,24,25-tris(4-carboxyphenyl)-2,5,8,15,18,21-hexaoxatricyclo[20.4.0.09,14]hexacosa-1(22),9(14),10,12,23,25-hexaen-11-yl]benzoic acid

Standard CAS: 1620959-59-2 Multi CAS: No

Basic Information

CAS
1620959-59-2
Multi CAS
No
Molecular Formula
C48H40O14
Molecular Weight
840.800000
Exact Mass
840.241806
SMILES
C1COC2=C(C=C(C(=C2)C3=CC=C(C=C3)C(=O)O)C4=CC=C(C=C4)C(=O)O)OCCOCCOC5=C(C=C(C(=C5)C6=CC=C(C=C6)C(=O)O)C7=CC=C(C=C7)C(=O)O)OCCO1
InChI
InChI=1S/C48H40O14/c49-45(50)33-9-1-29(2-10-33)37-25-41-42(26-38(37)30-3-11-34(12-4-30)46(51)52)60-22-18-58-20-24-62-44-28-40(32-7-15-36(16-8-32)48(55)56)39(31-5-13-35(14-6-31)47(53)54)27-43(44)61-23-19-57-17-21-59-41/h1-16,25-28H,17-24H2,(H,49,50)(H,51,52)(H,53,54)(H,55,56)
InChIKey
BNYWIYSTROPLRD-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
62
Aromatic heavy atom count
36
Fraction Csp3
0.17
Rotatable bonds
8
H-bond acceptors
10
H-bond donors
4
Molar refractivity
226.08
TPSA
204.58

LogP / Solubility

WLOGP
8.41
MLOGP
7.48
XLogP3
7.6
Consensus LogP
7.83
Log S (ESOL)
-10.25
Class (ESOL)
Insoluble
Log S (Ali)
-12.53
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-13.07
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.88

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
7.5

Get In Touch

Contact Us